GeniPhys, LLC
Collymer™, a polymerizable collagen scaffold material for custom collagen-based tissue engineering constructs
- Sector
- Biotech
- Headquarters
- ZIONSVILLE, IN
- Founded
- 2021
- Latest Form D
- $3M, Feb 2026
- Total capital
- $9.1M
- Federal grants
- $1.7M
- 2 awards · 2019–2022
- Rank in peer group#10 of 20
- Private capital raised
- $7.5M
- 2 Form D · last Feb 2026
- 8 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$3M
- Private capital raisedForm D · SEC · 1st filing$4.5M
- Federal grantNSF · Phase II · SBIR Phase II:Regenerative Tissue Filler for Breast Conserving Surgery and Other Soft Tissue Restoration Needs$1.5M
- Federal grantNSF · Phase I · SBIR Phase I: Biologic Filler for Regenerating Tissue Following Breast Conserving Surgery$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
41months
from GeniPhys, LLC’s first federal award to its first private round.
- First federal award · Jul 2019
- NSF · $225K
- First Form D · Nov 2022
- $4.5M · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 20 peers
Line = medianBiotech · Material
- Federal grants#10 · top 50%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Andrew S. EiblingExecutive Officer, DirectorNamed in SEC Form D filings
- John DeFordDirectorNamed in SEC Form D filings
- R. Matthew NeffDirectorNamed in SEC Form D filings
- Scot A. HarbinExecutive OfficerNamed in SEC Form D filings
- Shaun S HawkinsDirectorNamed in SEC Form D filings
- Sherry L. HarbinExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingBiologic Filler For Regenerating Tissue In WoundsUSPTOApplication 63015946
- PendingHigh-strength Collagen Compositions And Methods Of UseUSPTOApplication 63002644
- PendingBiologic Filler For Regenerating Tissue In WoundsUSPTOApplication 62966398
Show all 4 patent records
- Biologic Filler For Regenerating Tissue In WoundsApplication 63015946Pending
- High-strength Collagen Compositions And Methods Of UseApplication 63002644Pending
- Biologic Filler For Regenerating Tissue In WoundsApplication 62966398Pending
- Methods And Compositions For Matrix PreparationApplication PCTUS2018016069Pending
Related companies, and why
- Outer Biosciences IncSimilar federal contract value in Biotech · null in contracts
- PreleniaSimilar federal contract value in Biotech · null in contracts
- INTEGRATED DYNAMICS, INC.Similar federal contract value in Biotech · null in contracts
- Betula Extractives, LLC.Similar federal contract value in Biotech · null in contracts
- Sepragen CorporationSimilar federal contract value in Biotech · null in contracts
- A-Alpha Bio, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .